Protection of telomeres 1 protein levels are associated with telomere length in gastric cancer

International Journal of Molecular Medicine

Volumn 21, Issue 5, 2008, Pages 599-604

  Fujii, Kiyomu ^a   Sasahira, Tomonori ^a   Moriwaka, Yukiko ^a   Oue, Naohide ^b   Yasui, Wataru ^b   Kuniyasu, Hiroki ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Gastric cancer; Telomere; Telomere length

Indexed keywords

NOCODAZOLE; PROTECTION OF TELOMERE 1 PROTEIN; TELOMERE BINDING PROTEIN; UNCLASSIFIED DRUG; POT1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER STAGING; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOCYTE; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SOUTHERN BLOTTING; STOMACH CANCER; STOMACH EPITHELIUM; STOMACH MUCOSA; TELOMERE; ANIMAL; CYTOLOGY; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

AGED; ANIMALS; CELL LINE, TUMOR; FEMALE; GASTRIC MUCOSA; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; STOMACH NEOPLASMS; TELOMERE; TELOMERE-BINDING PROTEINS;

EID: 46449113385     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.21.5.599     Document Type: Article

References (22)

1. Harley CB: Human aging and telomeres. Ciba Found Symp 211: 129-139, 1997.
2. Greider CW and Blackburn EH: Telomeres, telomerase and cancer. Sci Am 274: 92-97, 1996.
3. Holt SE, Wright WE and Shay JW: Multiple pathways for the regulation of telomerase activity. Eur J Cancer 33: 761-766, 1997.
4. Weng NP, Palmer LD, Levine BL, Lane HC, June CH and Hodes RJ: Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol Rev 160: 43-54, 1997.
5. Kuniyasu H, Kitadai Y, Mieno H and Yasui W: Helicobactor pylori infection is closely associated with telomere reduction in gastric mucosa. Oncology 65: 275-282, 2003.
6. Kuniyasu H, Domen T, Hamamoto T, Yokozaki H, Yasui W, Tahara H and Tahara E: Expression of human telomerase RNA is an early event of stomach carcinogenesis. Jpn J Cancer Res 88: 103-107, 1997.
7. Tahara H, Kuniyasu H, Yokozaki H, Yasui W, Shay JW, Ide T and Tahara E: Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res 1: 1245-1251, 1995.
8. Baumann P and Cech TR: Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 292: 1171-1175, 2001.
9. Lei M, Baumann P and Cech TR: Cooperative binding of single-stranded telomeric DNA by the Pot1 protein of Schizosaccharomyces pombe. Biochemistry 41: 14560-14568, 2002.
10. Baumann P, Podell E and Cech TR: Human Pot1 (protection of telomeres) protein: cytolocalization, gene structure, and alternative splicing. Mol Cell Biol 22: 8079-8087, 2002.
11. Wei C and Price CM: Cell cycle localization, dimerization, and binding domain architecture of the telomere protein cPot1. Mol Cell Biol 24: 2091-2102, 2004.
12. Loayza D and De Lange T: POT1 as a terminal transducer of TRF1 telomere length control. Nature 423: 1013-1018, 2003.
13. Colgin LM, Baran K, Baumann P, Cech TR and Reddel RR: Human POT1 facilitates telomere elongation by telomerase. Curr Biol 13: 942-946, 2003.
14. Ye JZ, Hockemeyer D, Krutchinsky AN, Loayza D, Hooper SM, Chait BT and De Lange T: POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev 18: 1649-1654, 2004.
15. Kondo T, Oue N, Yoshida K, Mitani Y, Naka K, Nakayama H and Yasui W: Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma. Cancer Res 64: 523-529, 2004.
16. Lin X, Gu J, Lu C, Spitz MR and Wu X: Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer. Clin Cancer Res 12: 5720-5725, 2006.
17. Sobin LH and Wittekind C (eds): UICC TNM Classification of Malignant Tumours. 6th edition, John Wiley & Sons Inc., New York, 2003.
18. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64: 31-49, 1965.
19. Kuniyasu H, Yasui W, Kitahara K, Naka K, Yokozaki H, Akama Y, Hamamoto T, Tahara H and Tahara E: Growth inhibitory effect of interferon-beta is associated with the induction of cyclin-dependent kinase inhibitor p27Kip1 in a human gastric carcinoma cell line. Cell Growth Differ 8: 47-52, 1997.
20. Kuniyasu H, Oue N, Wakikawa A, Shigeishi H, Matsutani N, Kuraoka K, Ito R, Yokozaki H and Yasui W: Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. J Pathol 196: 163-170, 2002.
21. Kuniyasu H, Yasui W, Shinohara H, Yano S, Ellis LM, Wilson MR, Bucana CD, Rikita T, Tahara E and Fidler IJ: Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancer. Am J Pathol 157: 1523-1535, 2000.
22. Greider CW: Telomere length regulation. Annu Rev Biochem 65: 337-365, 1996.